Injectable
Tren Esters 300
300 mg/mL
Tren Esters 300 combines acetate, enanthate, and hexahydrobenzylcarbonate esters of trenbolone. The three esters provide different release characteristics without reducing trenbolone-related risk.
Product Summary
- Product
- Tren Esters 300
- Strength
- 300 mg/mL
- Dosage Form
- Injectable
Product Information
Professional injectable product profile.
Product overview: Tren Esters 300 is an oil-based injectable blend containing three trenbolone esters: acetate, enanthate, and hexahydrobenzylcarbonate. The total trenbolone ester content is 300 mg per 1 mL.
Formulation profile: The ester combination provides different release characteristics within one trenbolone-based formulation. The blend format changes ester presentation but does not reduce the underlying concerns associated with trenbolone exposure.
Important considerations: Relevant concerns include androgenic, endocrine, reproductive, cardiovascular, lipid, and psychological risks. This page excludes non-medical preparation language and physique claims while retaining the verified composition. Combining three esters changes release characteristics but not the core trenbolone exposure concern. The blend is therefore documented by ester identity, composition, carrier details, release-profile distinction, and source-supported professional risk context clearly.
| Product name | Tren Esters 300 |
|---|---|
| Strength | 300 mg/mL |
| Active ingredient or blend | Trenbolone Acetate, Trenbolone Enanthate, and Trenbolone Hexahydrobenzylcarbonate |
| Composition per 1 mL | Trenbolone Acetate 100 mg Trenbolone Enanthate 100 mg Trenbolone Hexahydrobenzylcarbonate 100 mg Total trenbolone esters: 300 mg Oil-based injectable solution |
| Dosage form | Oil-based injectable solution |
| Carrier oil | Pharmaceutical-grade carrier oil; benzyl benzoate; benzyl alcohol; Miglyol 840 |
| Pharmaceutical grade | Pharmaceutical grade carrier system stated in the source |
Inquiry
Request product information for Tren Esters 300.
For product enquiries, portfolio discussion, or category coordination, email info@3xpharma.com.